400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2025-10-14
肥胖和相关疾病疗法研发商
医药研发/制造
化学&生物药
Bain Capital;
Bain Capital;
Adage Capital Partners LP;
Adage Capital Partners LP;
CPP Investments;
Invus;
Janus Henderson Investors;
Perseverance Capital;
Qatar Investment Authority;
Royalty Pharma;
Surveyor Capital;
T. Rowe Price;
Atlas Venture;
Bain Capital;
RTW Investments;
Sirona Capital
2024-10-31
皮下给药制剂研发商
医药研发/制造
化学&生物药
诺和诺德;
诺和诺德;
SR One;
SR One;
TPG Life Sciences Innovations;
RA Capital;
Royalty Pharma;
Eli Lilly;
Braidwell;
BVF Partners;
Catalio Capital Management;
Checkpoint Capital;
Deep Track Capital;
General Catalyst;
Janus Henderson Investors;
Kearny Venture Partners;
Logos Capital;
Marshall Wace;
Samsara BioCapital;
Woodline Partners;
SVB Securities;
Paradigm BioCapital
2021-11-22
疾病药物研发商
医药研发/制造
化学&生物药
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10